Our purpose was to investigate the relationship between FGF‐23 concentration and subsequent development of hyperphosphatemia and progression of CKD and determine the clinical relevance of increased FGF‐23 concentration in normophosphatemic dogs with CKD. This evidence concerns the gene FGF23 and chronic kidney disease.